title: Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use.
authors.forename: J
authors.initials: J
authors.lastname: Berkeley
authors.forename: H
authors.initials: H
authors.lastname: Lunt
authors.forename: C
authors.initials: C
authors.lastname: Frampton
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D009520:New Zealand
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin